156 related articles for article (PubMed ID: 38630690)
1. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
Tadokoro Y; Takeda D; Murakami A; Yatagai N; Saito I; Arimoto S; Kakei Y; Akashi M; Hasegawa T
PLoS One; 2023; 18(8):e0290357. PubMed ID: 37594996
[TBL] [Abstract][Full Text] [Related]
3. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous Carbon Dioxide Decreases Immunosuppressive Factors in Squamous Cell Carcinoma In Vivo.
Yatagai N; Hasegawa T; Amano R; Saito I; Arimoto S; Takeda D; Kakei Y; Akashi M
Biomed Res Int; 2021; 2021():5568428. PubMed ID: 34307656
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
Takeda D; Hasegawa T; Ueha T; Imai Y; Sakakibara A; Minoda M; Kawamoto T; Minamikawa T; Shibuya Y; Akisue T; Sakai Y; Kurosaka M; Komori T
PLoS One; 2014; 9(7):e100530. PubMed ID: 24988190
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous carbon dioxide application inhibits muscle atrophy after fracture in rats.
Inoue M; Sakai Y; Oe K; Ueha T; Koga T; Nishimoto H; Akahane S; Harada R; Lee SY; Niikura T; Kuroda R
J Orthop Sci; 2020 Mar; 25(2):338-343. PubMed ID: 31031109
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous carbon dioxide application suppresses bone destruction caused by breast cancer metastasis.
Takemori T; Kawamoto T; Ueha T; Toda M; Morishita M; Kamata E; Fukase N; Hara H; Fujiwara S; Niikura T; Kuroda R; Akisue T
Oncol Rep; 2018 Oct; 40(4):2079-2087. PubMed ID: 30066936
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous carbon dioxide application with hydrogel prevents muscle atrophy in a rat sciatic nerve crush model.
Nishimoto H; Inui A; Ueha T; Inoue M; Akahane S; Harada R; Mifune Y; Kokubu T; Nishida K; Kuroda R; Sakai Y
J Orthop Res; 2018 Jun; 36(6):1653-1658. PubMed ID: 29193246
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
[TBL] [Abstract][Full Text] [Related]
12. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).
Jaitovich A; Angulo M; Lecuona E; Dada LA; Welch LC; Cheng Y; Gusarova G; Ceco E; Liu C; Shigemura M; Barreiro E; Patterson C; Nader GA; Sznajder JI
J Biol Chem; 2015 Apr; 290(14):9183-94. PubMed ID: 25691571
[TBL] [Abstract][Full Text] [Related]
13. Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma.
Cannon T; Shores C; Yin X; Dahlman J; Guttridge D; Lai V; George J; Buzkova P; Couch M
Head Neck; 2008 Mar; 30(3):320-6. PubMed ID: 17657796
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining with cytokeratin combining semi-serial sections for detection of cervical lymph node metastases of oral squamous cell carcinoma.
Guo CB; Li YA; Gao Y
Auris Nasus Larynx; 2007 Sep; 34(3):347-51. PubMed ID: 17399927
[TBL] [Abstract][Full Text] [Related]
15. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
16. Detection of micro-metastasis using cytokeratins (AE1/AE3) in haematoxylin & eosin-stained N
Sinha GM; Hegde V
Indian J Med Res; 2023 Apr; 157(4):316-321. PubMed ID: 37282394
[TBL] [Abstract][Full Text] [Related]
17. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
[TBL] [Abstract][Full Text] [Related]
18. The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.
Bonetto A; Rupert JE; Barreto R; Zimmers TA
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929469
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
20. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
